Merck KGaA (OTCMKTS:MKGAF) Sees Large Growth in Short Interest

Merck KGaA (OTCMKTS:MKGAF) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 284,600 shares, an increase of 19.7% from the October 15th total of 237,800 shares. Based on an average daily volume of 300 shares, the days-to-cover ratio is presently 948.7 days.

Merck KGaA Stock Down 1.3 %

Shares of OTCMKTS MKGAF traded down $2.00 during trading on Friday, hitting $150.00. 253 shares of the company traded hands, compared to its average volume of 513. Merck KGaA has a fifty-two week low of $144.73 and a fifty-two week high of $200.56. The firm has a market capitalization of $19.39 billion, a price-to-earnings ratio of 22.03 and a beta of 0.96. The business’s fifty day moving average is $170.99 and its 200 day moving average is $175.92. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group upgraded shares of Merck KGaA to a “strong-buy” rating in a report on Thursday, September 19th.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.